A significant change for one of Australia's leading patient advocates with the co-founder and CEO of NeuroEndocrine Cancer Australia departing the organisation after 13 years.
Major change for leading patient advocate with move to emerging Australian company
October 13, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 2 May
May 2, 2025 - - Podcast -
Major parties share commitment to the HTA Review process and no pre-election funding
May 1, 2025 - - Latest News -
Dimerix secures one of the largest licensing deals in Australian biotechnology
May 1, 2025 - - Australian Biotech -
New report shows US government more interested in cheese names than the PBS
May 1, 2025 - - Latest News -
Merck Healthcare leader joins Brain Cancer Australia charity board
April 30, 2025 - - Latest News -
Icon partners with Nuffield Health for three new cancer centres
April 30, 2025 - - Latest News -
PBS listing for Otsuka and Lundbeck's long-acting injectable for schizophrenia
April 30, 2025 - - Latest News